Acquisition of Es ketamine 28 mg Powder solution nasal spray Fr 0.2 ml

This tender concerns the acquisition of Es ketamine, a pharmaceutical product specified as a 28 mg powder for nasal spray solution, presented in a 0.2 ml container (Fr). Es ketamine is a medication used for the treatment of depression and sometimes for anesthesia. The procurement is for a specific formulation and delivery method, indicating a need for this particular therapeutic agent in a nasal spray format. The contracting entity requires a supply of this medication, likely for clinical or therapeutic purposes. Bidders must be authorized suppliers of pharmaceutical products and capable of meeting the rigorous quality and regulatory standards applicable to medical supplies. The tender documents will detail the required quantities, delivery schedules, and packaging specifications. Ensuring the stability, efficacy, and proper handling of the Es ketamine nasal spray throughout the supply chain is paramount. This acquisition is vital for providing access to this specific treatment option.

This is a supplies contract in the health and medical services and general supplies sectors. Located in Portugal, Europe, this opportunity is open to firms and consortiums, with an estimated budget of EUR 28,200.

Published through base_gov_pt, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.